CRIZOTINIB FUNDAMENTALS EXPLAINED

Ceritinib is a tyrosine kinase inhibitor that selectively and potently inhibits anaplastic lymphoma kinase (ALK). In usual physiology, ALK features as a vital phase in the event and function of anxious method tissue. On the other hand, chromosomal translocation and fusion give rise to an oncogenic method of ALK that's been implicated in development